방광의 요로상피암종에서 p16, Rb, FHIT 단백 발현에 대한 연구
Expression of p16, Rb and FHIT Proteins in Urothelial Carcinoma of the Urinary Bladder
2
조회
0
다운로드
1
인용
0
참고문헌
초록
Abstract
Background : The goal of this study was to investigate the expression of p16, retinoblastoma(Rb) and fragile histidine triad (FHIT) proteins in urothelial carcinomas of the urinary bladder, and to evaluate the relationship between clinicopathlogic parameters and each protein expression level. Methods : The expression of p16, Rb, and FHIT proteins were studied in 176 patients with urothelial carcinoma of the urinary bladder by immunohistochemistry. Results : The diffuse positive expression of the p16 protein was significantly associated with high grade and advanced tumor depth (p=0.007 and p=0.020). The loss of the Rb protein was significantly associated with old age and disease recurrence (p=0.020 and 0.037). The loss of the FHIT protein was significantly associated with advanced tumor depth (p=0.002). Conclusions : Our data suggest that p16 and FHIT proteins may be involved in the progression of urothelial carcinoma. In addition, p16 may be a useful prognostic marker for individual urothelial carcinoma patients.
참고문헌 (17)
- Mhawech-Fauceglia P, "Genetic alterations in urothelial bladder carcinoma: an updated review", Cancer, 106, pp.1205~1216 (2006)
- Borden LS Jr, "Bladder cancer", Curr Opin Oncol, 15, pp.227~233 (2003)
- Rocco JW, "p16(MTS-1", CDKN2, Exp Cell Res, pp.2001, 264[DOI]
- Williamson MP, "p16 (CDKN2) is a major deletion target at 9p21 in bladder cancer", Hum Mol Genet, 4, pp.1569~1577 (1995)
- Yeager TR, "Overcoming cellular senescence in human cancer pathogenesis", Genes Dev, 12, pp.163~174 (1998)
- Kruger S, "P16 immunoreactivity is an independent predictor of tumor progression in minimally invasive urothelial bladder carcinoma", Eur Urol, 47, pp.463~467 (2005)
- Hitchings AW, "Prediction of progression in pTa and pT1 bladder carcinomas with p53, p16 and pRb", Br J Cancer, 91, pp.552~557 (2004)
- Shariat SF, "p53, p21, pRB, and p16 expression predict clinical outcome in cystectomy with bladder cancer", J Clin Oncol, 22, pp.1014~1024 (2004)
- Le Frere-Belda MA, "Profiles of the 2 INK4a gene products, p16 and p14ARF, in human reference urothelium and bladder carcinomas, according to pRb and p53 protein status", Hum Pathol, 35, pp.817~824 (2004)
- Yin M, "p16ink4 immunoreactivity is a reliable marker for urothelial carcinoma in situ", Hum Pathol, 39, pp.527~535 (2008)
- Klaes R, "Overexpression of p16 (INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri", Int J Cancer, 92, pp.276~284 (2001)
- Chatterjee SJ, "Combined effects of p53, p21, and pRb expression in the progression of bladder transitional cell carcinoma", J Clin Oncol, 22, pp.1007~1013 (2004)
- Grossman HB, "p53 and RB expression predict progression in T1 bladder cancer", Clin Cancer Res, 4, pp.829~834 (1998)
- Cordon-Cardo C, "Cooperative effects of p53 and pRB alterations in primary superficial bladder tumors", Cancer Res, 57, pp.1217~1221 (1997)
- Santos LL, "Expression of cell-cycle regulatory proteins and their prognostic value in superficial low-gradeurothelial cell carcinoma of the bladder", Eur J Surg Oncol, 29, pp.74~80 (2003)
- Vecchione A, "Inactivation of the FHIT gene favors bladder cancer development", Clin Cancer Res, 10, pp.7607~7612 (2004)
- Skopelitou AS, "FHIT gene expression in human urinary bladder transitional cell carcinomas", In Vivo, 15, pp.169~173 (2001)